Zimmer CAS PSI X-Ray Knee in TKA (Total Knee Arthroplasty)
Evaluation of Zimmer® CAS PSI X-Ray Knee in Total Knee Arthroplasty (TKA): Technical Outcomes
1 other identifier
observational
9
0 countries
N/A
Brief Summary
The objective of the observational study is to assess the positioning of customized guides designed from patients X-Rays (Zimmer® X-Ray PSI Knee) using optical navigation in primary total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2015
CompletedFirst Posted
Study publicly available on registry
July 21, 2015
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedJune 25, 2018
June 1, 2018
2 years
July 17, 2015
June 20, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
assess the positioning accuracy and precision of customized X-RAY PSI guides using the Sesamoid Optical Navigation system in Total Knee Arthroplasty
Intra-operative
Secondary Outcomes (1)
assess the correlation between planned vs. actual component size and bony resection thickness
Intra-operative
Study Arms (1)
X-Ray PSI Group
Male or female patients, over 18 years old and with indication of total knee arthroplasty
Interventions
Eligibility Criteria
Patients over 18 years old with indication of Total Knee Arhtroplasty
You may qualify if:
- Male or female
- Needs a primary TKA and he/she is Persona® knee implant compatible
- Diagnosed with non-inflammatory degenerative joint disease (e.g., osteoarthritis, post-traumatic arthritis, avascular necrosis, etc.)
- Over 18 years old
- Able to:
- Understand what participation in the study entails and willing to consent (patient or his/her legal guardian) to participate in the study by signing and dating an IRB/EC approved inform consent form. and
- Follow surgeon/staff instructions, and
- Return for all follow-up evaluations, and
- Able and willing to undergo a preoperative radiographs (all cases)
- Meets an acceptable preoperative medical clearance and is free of or treated for cardiac, pulmonary, hematological or other conditions that would pose excessive operative risk.
- Has a presence of varus or valgus deformity of 15 degrees or less.
You may not qualify if:
- Is currently enrolled in an investigational new drug or device study
- Has an active infection (including septic knee, distant infection, or osteomyelitis)
- Has neurological disorders (including, but not limited to Parkinson's disease)
- Has had a prior ipsilateral unicompartmental knee arthroplasty, TKA, knee fusion or patellectomy.
- Has hip or knee ankylosis.
- Have indications of intra- and/or extra-articular deformations that would eliminate or tend to eliminate adequate implant support or prevent the use of an appropriately sized implant, such as polio, history of tibial plateau fracture, etc.
- Has any metal within 150 mm of the joint line for the operative-side knee.
- Has knee deformities greater than 15 degrees of fixed varus, valgus, or flexion contracture on initial physical examination.
- Is a female who is pregnant or lactating
- Is currently involvement in any personal injury litigation, medical-legal or worker's compensation claims
- Has arterial disease or stents that would exclude the use of a tourniquet.
- Has insufficient quality or quantity of bone to support the implant due to prior knee surgery (or surgeries), cancer, metabolic bone disease, osteoporosis/osteopnea (diagnosed or treated with medication), active/old/remote infection, etc.
- Has a mental condition that may interfere with his/her ability to give an informed consent or interfere with his/her ability or willingness to fulfill the requirements of the study.
- Has a condition that would place excessive demands on the implant (e.g., Charcot's joints, muscle deficiencies, multiple joint disabilities, skeletal immaturity, etc.).
- Has collateral ligament insufficiency.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
- Maisonneuve-Rosemont Hospitalcollaborator
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2015
First Posted
July 21, 2015
Study Start
May 1, 2016
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
June 25, 2018
Record last verified: 2018-06